Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Here's is How to Trade

Shares of Adma Biologics (ADMA) have gained 1.1% over the past four weeks to close the last trading session at $5.36, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$6.88 indicates a potential upside of 28.4%.The mean estimate comprises four short-term price targets with a standard deviation of $1.44. While the lowest estimate of$6 indicates an 11.9% increase from the current ...